Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-035386

Senior Vice President and CFO sold 3,922 shares at $9.45 ($37,063)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-12-04 Sale : show line 1 in the form −3,922 $9.45 $37,063 133,461 D
Open-market sales · 3,922 sh · avg $9.45 · $37,063
Loading xslF345X03/form4.xml…